163 related articles for article (PubMed ID: 35743485)
21. Comparative analysis of photobiomodulation therapy and transcutaneous electrical nerve stimulation for burning mouth: a randomized clinical trial.
Medeiros CKS; Serrão MDCPN; de Lima AAS; da Silveira ÉJD; de Oliveira PT
Clin Oral Investig; 2023 Oct; 27(10):6157-6165. PubMed ID: 37656286
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the effects of photobiomodulation therapy and ozone applications after gingivectomy and gingivoplasty on postoperative pain and patients' oral health-related quality of life.
Uslu MÖ; Akgül S
Lasers Med Sci; 2020 Sep; 35(7):1637-1647. PubMed ID: 32435906
[TBL] [Abstract][Full Text] [Related]
23. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life.
Niklander S; Veas L; Barrera C; Fuentes F; Chiappini G; Marshall M
Braz Oral Res; 2017 Jan; 31():e14. PubMed ID: 28099580
[TBL] [Abstract][Full Text] [Related]
24. The effect of xerostomia and hyposalivation on the quality of life of patients with type II diabetes mellitus.
Molania T; Alimohammadi M; Akha O; Mousavi J; Razvini R; Salehi M
Electron Physician; 2017 Nov; 9(11):5814-5819. PubMed ID: 29403624
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Photobiomodulation in Temporomandibular Disorder-Related Pain Using a 635 nm Diode Laser: A Randomized, Blinded, and Placebo-Controlled Clinical Trial.
Monteiro L; Ferreira R; Resende T; Pacheco JJ; Salazar F
Photobiomodul Photomed Laser Surg; 2020 May; 38(5):280-288. PubMed ID: 32427553
[No Abstract] [Full Text] [Related]
26. Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial.
Fidelix T; Czapkowski A; Azjen S; Andriolo A; Neto PH; Trevisani V
Clin Rheumatol; 2018 Mar; 37(3):729-736. PubMed ID: 29119483
[TBL] [Abstract][Full Text] [Related]
27. Sensory-motor and cardiorespiratory sensory rehabilitation associated with transcranial photobiomodulation in patients with central nervous system injury: Trial protocol for a single-center, randomized, double-blind, and controlled clinical trial.
Pinto AP; Guimarães CL; Souza GADS; Leonardo PS; Neves MFD; Lima FPS; Lima MO; Lopes-Martins RAB
Medicine (Baltimore); 2019 Jun; 98(25):e15851. PubMed ID: 31232920
[TBL] [Abstract][Full Text] [Related]
28. Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy.
Palma LF; Gonnelli FAS; Marcucci M; Dias RS; Giordani AJ; Segreto RA; Segreto HRC
Lasers Med Sci; 2017 May; 32(4):827-832. PubMed ID: 28258315
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the psychopathological profile, quality of life, and cost-effectiveness of oral lichen planus patients treated with photobiomodulation.
Sobral SS; da Silva Brandão EH; de Barros Gallo C; Molon A; Sobral APT; de Fátima Teixeira da Silva D; Motta LJ; Dos Santos Franco AL; Rodrigues MFSD
Clin Oral Investig; 2022 Jan; 26(1):719-728. PubMed ID: 34251533
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the salivary function of patients in treatment with radiotherapy for head and neck cancer submitted to photobiomodulation.
Ribeiro LN; Lima MH; Carvalho AT; Albuquerque RF; Leão JC; Silva IH
Med Oral Patol Oral Cir Bucal; 2021 Jan; 26(1):e14-e20. PubMed ID: 33247577
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled trial of a traditional herbal formula, Yukmijihwang-tang in elderly subjects with xerostomia.
Han G; Ko SJ; Kim J; Oh JY; Park JW; Kim J
J Ethnopharmacol; 2016 Apr; 182():160-9. PubMed ID: 26902832
[TBL] [Abstract][Full Text] [Related]
32. Photobiomodulation in the Treatment of Dysgeusia in Patients with Long COVID: A Single-Blind, Randomized Controlled Trial.
Parreira LFS; Pinheiro SL; Fontana CE
Photobiomodul Photomed Laser Surg; 2024 Mar; 42(3):215-224. PubMed ID: 38416635
[No Abstract] [Full Text] [Related]
33. Outcomes of whole-body photobiomodulation on pain, quality of life, leisure physical activity, pain catastrophizing, kinesiophobia, and self-efficacy: a prospective randomized triple-blinded clinical trial with 6 months of follow-up.
Navarro-Ledesma S; Carroll JD; González-Muñoz A; Burton P
Front Neurosci; 2024; 18():1264821. PubMed ID: 38356644
[TBL] [Abstract][Full Text] [Related]
34. [State of art of photobiomodulation in the management of radiotherapy adverse events: Indications and level of evidence].
Klausner G; Bensadoun RJ; Champion A; Benzaquen D; Canova CH; Claren A; Mancuso V; Suhl J; Balard R; Troussier I
Cancer Radiother; 2021 Oct; 25(6-7):584-592. PubMed ID: 34272181
[TBL] [Abstract][Full Text] [Related]
35. Acute and cumulative benefits of Photobiomodulation for xerostomia: A systematic review and meta-analysis.
Galiano-Castillo N; Liu L; Lozano-Lozano M; Tumilty S; Cantarero-Villanueva I; Baxter GD
Oral Dis; 2021 Jul; 27(5):1115-1126. PubMed ID: 32964596
[TBL] [Abstract][Full Text] [Related]
36. A Clinical Study on the Efficacy and Tolerability of a New Topical Gel and Toothpaste in Patients with Xerostomia: A Randomized Controlled Trial.
López Jornet P; Hernandez L; Gomez García F; Galera Molero F; Pons-Fuster López E; Tvarijonaviciute A
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884343
[TBL] [Abstract][Full Text] [Related]
37. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.
Epstein JB; Raber-Durlacher JE; Lill M; Linhares YP; Chang J; Barasch A; Slief RI; Geuke M; Zecha JA; Milstein DM; Tzachanis D
Support Care Cancer; 2017 Feb; 25(2):357-364. PubMed ID: 27655559
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial.
Salinas-Gilabert C; Gómez García F; Galera Molero F; Pons-Fuster E; Vander Beken S; Lopez Jornet P
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678659
[TBL] [Abstract][Full Text] [Related]
39. Interventions for the treatment of xerostomia: A randomized controlled clinical trial.
Marín C; Díaz-de-Valdés L; Conejeros C; Martínez R; Niklander S
J Clin Exp Dent; 2021 Feb; 13(2):e104-e111. PubMed ID: 33574994
[TBL] [Abstract][Full Text] [Related]
40. Hyposalivation and xerostomia among Parkinson's disease patients and its impact on quality of life.
Barbe AG; Heinzler A; Derman S; Hellmich M; Timmermann L; Noack MJ
Oral Dis; 2017 May; 23(4):464-470. PubMed ID: 27976483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
